IRWD Q3 2017 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$603M

Q3 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$87M+31.3% YoY

Gross Profit

$81M93.0% margin

Operating Income

-$19M-22.4% margin

Net Income

-$32M-37.2% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+33.4%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$33M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$625M

Total Liabilities

$643M

Stockholders' Equity

-$18M

Cash & Equivalents

$163M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$87M	$66M	+31.3%
Gross Profit	$81M	$29M	+182.5%
Operating Income	-$19M	-$28M	+31.3%
Net Income	-$32M	-$33M	+2.7%